Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans
Anne-Marie Faucher
1
,
Murray D. Bailey
1
,
Pierre L Beaulieu
1
,
Christian Brochu
1
,
Jean-Simon Duceppe
1
,
Jean-Marie Ferland
1
,
Elise Ghiro
1
,
Vida Gorys
1
,
Ted Halmos
1
,
Stephen H Kawai
1
,
Martin Poirier
1
,
Bruno Simoneau
1
,
CHARLES A. COLE
1
,
Montse Llinas-Brunet
1
1
Chemistry Department, Boehringer Ingelheim (Canada) Ltd., Research and Development, 2100 Cunard Street, Laval, (Québec) Canada H7S 2G5
|
Тип публикации: Journal Article
Дата публикации: 2004-07-21
scimago Q1
wos Q1
БС1
SJR: 1.235
CiteScore: 8.7
Impact factor: 5.0
ISSN: 15237060, 15237052
PubMed ID:
15330643
Organic Chemistry
Biochemistry
Physical and Theoretical Chemistry
Краткое описание
The synthesis of BILN 2061, an NS3 protease inhibitor with proven antiviral effect in humans, was accomplished in a convergent manner from four building blocks. The procedure described here was suitable for the preparation of multigram quantities of BILN 2061 for preclinical pharmacological evaluation.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
2
3
4
5
6
7
8
|
|
|
Organic Process Research and Development
8 публикаций, 8.16%
|
|
|
Journal of Organic Chemistry
5 публикаций, 5.1%
|
|
|
Chemical Reviews
5 публикаций, 5.1%
|
|
|
Organic Letters
5 публикаций, 5.1%
|
|
|
Journal of Organometallic Chemistry
4 публикации, 4.08%
|
|
|
Journal of Medicinal Chemistry
4 публикации, 4.08%
|
|
|
Bioorganic and Medicinal Chemistry
3 публикации, 3.06%
|
|
|
Bioorganic and Medicinal Chemistry Letters
3 публикации, 3.06%
|
|
|
Antimicrobial Agents and Chemotherapy
3 публикации, 3.06%
|
|
|
Tetrahedron
2 публикации, 2.04%
|
|
|
Angewandte Chemie - International Edition
2 публикации, 2.04%
|
|
|
Angewandte Chemie
2 публикации, 2.04%
|
|
|
European Journal of Organic Chemistry
2 публикации, 2.04%
|
|
|
Chemistry - A European Journal
2 публикации, 2.04%
|
|
|
Advanced Synthesis and Catalysis
2 публикации, 2.04%
|
|
|
Topics in Heterocyclic Chemistry
2 публикации, 2.04%
|
|
|
Beilstein Journal of Organic Chemistry
1 публикация, 1.02%
|
|
|
Future Virology
1 публикация, 1.02%
|
|
|
Molecules
1 публикация, 1.02%
|
|
|
Applied Biochemistry and Biotechnology
1 публикация, 1.02%
|
|
|
Journal of Gastroenterology
1 публикация, 1.02%
|
|
|
Acta Pharmacologica Sinica
1 публикация, 1.02%
|
|
|
Science
1 публикация, 1.02%
|
|
|
Bioorganic Chemistry
1 публикация, 1.02%
|
|
|
Antiviral Research
1 публикация, 1.02%
|
|
|
Journal of Hepatology
1 публикация, 1.02%
|
|
|
Journal of Biological Chemistry
1 публикация, 1.02%
|
|
|
Drug Discovery Today
1 публикация, 1.02%
|
|
|
Coordination Chemistry Reviews
1 публикация, 1.02%
|
|
|
1
2
3
4
5
6
7
8
|
Издатели
|
5
10
15
20
25
30
|
|
|
American Chemical Society (ACS)
28 публикаций, 28.57%
|
|
|
Wiley
26 публикаций, 26.53%
|
|
|
Elsevier
22 публикации, 22.45%
|
|
|
Springer Nature
7 публикаций, 7.14%
|
|
|
American Society for Microbiology
3 публикации, 3.06%
|
|
|
MDPI
2 публикации, 2.04%
|
|
|
Beilstein-Institut
1 публикация, 1.02%
|
|
|
Taylor & Francis
1 публикация, 1.02%
|
|
|
American Association for the Advancement of Science (AAAS)
1 публикация, 1.02%
|
|
|
American Society for Biochemistry and Molecular Biology
1 публикация, 1.02%
|
|
|
Georg Thieme Verlag KG
1 публикация, 1.02%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 1.02%
|
|
|
5
10
15
20
25
30
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
98
Всего цитирований:
98
Цитирований c 2024:
1
(1.02%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Faucher A. et al. Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans // Organic Letters. 2004. Vol. 6. No. 17. pp. 2901-2904.
ГОСТ со всеми авторами (до 50)
Скопировать
Faucher A., Bailey M. D., Beaulieu P. L., Brochu C., Duceppe J., Ferland J., Ghiro E., Gorys V., Halmos T., Kawai S. H., Poirier M., Simoneau B., COLE C., Llinas-Brunet M. Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans // Organic Letters. 2004. Vol. 6. No. 17. pp. 2901-2904.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1021/ol0489907
UR - https://doi.org/10.1021/ol0489907
TI - Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans
T2 - Organic Letters
AU - Faucher, Anne-Marie
AU - Bailey, Murray D.
AU - Beaulieu, Pierre L
AU - Brochu, Christian
AU - Duceppe, Jean-Simon
AU - Ferland, Jean-Marie
AU - Ghiro, Elise
AU - Gorys, Vida
AU - Halmos, Ted
AU - Kawai, Stephen H
AU - Poirier, Martin
AU - Simoneau, Bruno
AU - COLE, CHARLES A.
AU - Llinas-Brunet, Montse
PY - 2004
DA - 2004/07/21
PB - American Chemical Society (ACS)
SP - 2901-2904
IS - 17
VL - 6
PMID - 15330643
SN - 1523-7060
SN - 1523-7052
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2004_Faucher,
author = {Anne-Marie Faucher and Murray D. Bailey and Pierre L Beaulieu and Christian Brochu and Jean-Simon Duceppe and Jean-Marie Ferland and Elise Ghiro and Vida Gorys and Ted Halmos and Stephen H Kawai and Martin Poirier and Bruno Simoneau and CHARLES A. COLE and Montse Llinas-Brunet},
title = {Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans},
journal = {Organic Letters},
year = {2004},
volume = {6},
publisher = {American Chemical Society (ACS)},
month = {jul},
url = {https://doi.org/10.1021/ol0489907},
number = {17},
pages = {2901--2904},
doi = {10.1021/ol0489907}
}
Цитировать
MLA
Скопировать
Faucher, Anne-Marie, et al. “Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans.” Organic Letters, vol. 6, no. 17, Jul. 2004, pp. 2901-2904. https://doi.org/10.1021/ol0489907.